Zobrazeno 1 - 10
of 18
pro vyhledávání: '"W. Keith Henry"'
Autor:
Hans-Jürgen Stellbrink, Feifan Zhang, Maria Del Mar Masiá, Yazdan Yazdanpanah, Cynthia McCoig, Kati Vandermeulen, Maria Luisa Montes-ramírez, Marty St. Clair, Christopher J Bettacchi, Gary Richmond, Hans Jaeger, David A. Margolis, Kenneth Sutton, Kimberly Y. Smith, Keikawus Arastéh, Rodica Van Solingen-Ristea, Marie-Aude Khuong-Josses, Daniel Podzamczer, Graham H.R. Smith, W Keith Henry, William Spreen
Publikováno v:
Open forum infectious diseases
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Open Forum Infectious Diseases
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Open Forum Infectious Diseases
Background In the Long-Acting Antiretroviral Treatment Enabling Trial 2 (LATTE-2) phase 2b study, long-acting (LA) injectable cabotegravir + rilpivirine dosed every 8 weeks (Q8W) or every 4 weeks (Q4W) demonstrated comparable efficacy with daily oral
Autor:
Matthew J. Budoff, John Hammer, John T. Brooks, Charles C. J. Carpenter, Howard N. Hodis, W. Keith Henry, Timothy J. Bush, E. Turner Overton, Jason V. Baker, Lois Conley, Pragna Patel, Wendy J. Mack
Publikováno v:
Clinical Infectious Diseases. 53:826-835
Background. Persons with human immunodeficiency virus (HIV) infection are at risk for premature cardiovascular disease (CVD). Predictors of atherosclerotic disease progression in contemporary patients have not been well described. Methods. Using data
Publikováno v:
Current Opinion in HIV and AIDS. 4:176-182
To explore the mechanisms by which HIV infection and antiretroviral therapy (ART) may increase risk for atherosclerotic cardiovascular disease (CVD), with attention to the implications of earlier initiation of ART (i.e. at higher CD4 cell counts than
Autor:
Winston Cavert, Donald I. Abrams, W. Keith Henry, Rodger D. MacArthur, Grace Peng, James D. Neaton, Joshua Rapkin, Michael J. Silverberg, Jason V. Baker
Publikováno v:
AIDS. 22:841-848
Background: Reductions in AIDS-related morbidity and mortality following the advent of combination antiretroviral therapy have coincided with relative increases in chronic non-AIDS end-organ diseases among HIV+ patients. Objective: To examine the ass
Autor:
Beverly Alston, Scott R. Evans, Robert Zackin, Judith A. Aberg, Francesca J. Torriani, W. Keith Henry, Carl J. Fichtenbaum, Susan W Brobst, Marshall J. Glesby, Susan Owens, Yijun Yang
Publikováno v:
AIDS Research and Human Retroviruses. 21:757-767
There is a paucity of information on the safety and efficacy of lipid-lowering therapy for dyslipidemia associated with human immunodeficiency virus (HIV) and antiretroviral therapy. Our objective was to determine whether fenofibrate and pravastatin
Autor:
W. Keith Henry, Judith S. Currier, Carl J. Fichtenbaum, James H. Stein, Judith A. Aberg, Michael P. Dubé, Marshall J. Glesby, John G. Gerber, Karen T. Tashima, Dennis L. Sprecher
Publikováno v:
Clinical Infectious Diseases. 37:613-627
Michael P. Dube, James H. Stein, Judith A. Aberg, Carl J. Fichtenbaum, John G. Gerber, Karen T. Tashima, W. Keith Henry, Judith S. Currier, Dennis Sprecher, and Marshall J. Glesby, for the Adult AIDS Clinical Trials Group Cardiovascular Subcommittee
Autor:
Susan Hunt, Calvin J. Cohen, Jeffrey P. Nadler, Allan Stein, Martin Markowitz, Neil M.H. Graham, Douglas L. Mayers, Steven Davis, Shannon Schrader, W. Keith Henry, Charles Farthing, Michael Sension, Stephen Brown, Werner Verbiest, Kurt Hertogs, Deborah Copeland, Harold A. Kessler, Richard Stryker, Melanie A. Thompson, Michael S. Saag, Michael H. Ames, Carol L. Brosgart, Gabriel Torres, Susan Jacobson, Jeffrey Goodgame, Howard Grossman, Marcus A. Conant, Ann C. Collier, Alex R. Rinehart, Jeffrey Galpin, Roberto C. Arduino
Publikováno v:
AIDS. 16:579-588
Objective To compare the effect of treatment decisions guided by phenotypic resistance testing (PRT) or standard of care (SOC) on short-term virological response. Design A prospective, randomized, controlled clinical trial conducted in 25 university
Autor:
Katherine Huppler Hullsiek, Amrit Singh, John T. Brooks, Eleanor Wilson, W. Keith Henry, Irini Sereti, Dave Gibson, Jason V. Baker, Kenneth A. Lichtenstein, Pragna Patel, Erna M. Kojic, Nur F. Önen
Publikováno v:
The Journal of infectious diseases. 210(9)
Effective combination antiretroviral therapy (ART) has dramatically increased but not fully restored the life expectancy of people with human immunodeficiency (HIV) infection [1, 2]. With increasing CD4+ T-lymphocyte counts and control of viral repli
Publikováno v:
Journal of the Association of Nurses in AIDS Care. 8:31-38
Assessment of the status and prognosis of an HIV-infected individual traditionally has been difficult for the clinician. The use of markers of disease progression such as CD4+ has been found to not be a complete indicator of the status of an HIV-infe
Autor:
Martin S. Hirsch, Manette T. Niu, Michael M. Lederman, Richard Haubrich, W. Keith Henry, Thomas C. Merigan, Scott M. Hammer, Holly Gundacker, John P. Phair, Michael Hughes, Robert T. Schooley, David Katzenstein
Publikováno v:
New England Journal of Medicine. 335:1081-1090
Background This double-blind study evaluated treatment with either a single nucleoside or two nucleosides in adults infected with human immunodeficiency virus type 1 (HIV-1) whose CD4 cell counts were from 200 to 500 per cubic millimeter. Methods We